Text Registration
Copyright Title
Approved drug products and legal requirements
Status
Published
on 13 Jun 2007
Year of Creation
1989
Copyright Claimant
United States Pharmacopeial Convention, Inc
Registration Number
TX0002554275
on 13 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0002554275) dated 13 Jun 2007, pertains to an electronic file (eService) titled "Approved drug products and legal requirements" created in 1989. The copyright holder is United States Pharmacopeial Convention, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to United States Pharmacopeial Convention, Inc.
Application Details
Registration Number
TX0002554275
Registration Date
6/13/2007
Year of Creation
1989
Place of First Publication
[S.l.]
Publisher Name
U.S. Pharmacopeial Convention
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
United States Pharmacopeial Convention, Inc
Physical Description
1 v
Series Statement
USP dispensing information v. 3
Notes
Material Matter Claimed Note: New Matter: "revisions and new text added."
Previous Registration Note: Prev. reg. 1980, no. 489-964
Statements
Application Title Statement: United States pharmacopeia drug information: vol. III
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.